EMCeFIV: Evaluation of the Prevalence of Asthma in a Cohort of Children Born After IVF (Aged 11-15) Compared With a Control Group

Sponsor
Hospital St. Joseph, Marseille, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT02636179
Collaborator
(none)
1,792
1
21
85.2

Study Details

Study Description

Brief Summary

Assisted Reproduction Technologies (ART) are increasingly being used worldwide as a result of fertility decline likely caused by changes in both environment and social behaviour. Considering this large usage, it is important to evaluate the potential risk on the health of children conceived using ART.

According to the literature, children born after ART are more likely to be at higher risk of health problems than spontaneously conceived ones. Interestingly, recent studies suggested an increase of asthma prevalence in children conceived using In Vitro Fertilization (IVF).

The purpose of this study is to evaluate the prevalence of asthma in school adolescents from a cohort of children born after In Vitro Fertilization (IVF), aged 11-15 years as compared to a control group composed of the same age range spontaneously conceived individuals.

The expected outcome of this study will provide new information regarding these children to ART professionals of and to their own families, by focusing on an age range (between 11 and 15 years) for which very little information is available to date.

Condition or Disease Intervention/Treatment Phase
  • Other: Comparative epidemiological survey

Detailed Description

The methodology is a comparative epidemiological survey, between children from a historical cohort born after intraconjugal In Vitro Fertilization (singleton or twin) aged 11-15 years and a control group recruited in schools after the agreement of Academic Inspection.

Parents of the two groups will be contacted either by phone calls or through written information given in the schools. They will receive the questionnaire and an information letter, once they give their agreement to be a part of the study.

Data collection will be conducted using two anonymous questionnaires. The first questionnaire was built based on items proposed in the international Health Behaviour in School-aged Children (HBSC) survey of the World Health Organization (WHO). The second questionnaire will be sent to parents. It will focus on the pregnancy and it will be used to adjust the analysis.

This study was submitted and approved by an Institutional Review Board in France (Comité de Protection des Personnes Sud-Méditerranée II) on 11th September 2015.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1792 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Evaluation of the Prevalence of Asthma in a Cohort of Children Born After In Vitro Fertilization (Aged 11-15) Compared With Spontaneously Conceived Children of the Same Age Range
Study Start Date :
Dec 1, 2015
Anticipated Primary Completion Date :
Jan 1, 2017
Anticipated Study Completion Date :
Sep 1, 2017

Arms and Interventions

Arm Intervention/Treatment
448 children

Children aged 11-15 years from a historical cohort born after In Vitro Fertilization or Intracytoplasmic Sperm Injection at Hospital Saint Joseph of Marseille

Other: Comparative epidemiological survey
The method used to select the control group will be the random sampling of eligible schools. It will be defined according to the place of schooling of the historic cohort of children. The children will be matched as close as possible based on sex, age, school class and type of school (public/private).

1344 children

Children aged 11-15 years born spontaneously schooling in the same geographic area as case

Other: Comparative epidemiological survey
The method used to select the control group will be the random sampling of eligible schools. It will be defined according to the place of schooling of the historic cohort of children. The children will be matched as close as possible based on sex, age, school class and type of school (public/private).

Outcome Measures

Primary Outcome Measures

  1. Prevalence of asthma [15 month]

    (will be assessed using the questionnaire of international Health Behaviour in School-aged Children [HBSC] survey).

Secondary Outcome Measures

  1. Prevalence of chronic diseases other than asthma [15 month]

    (will be assessed using the questionnaire of international Health Behaviour in School-aged Children [HBSC] survey)

  2. Physical well-being [15 month]

    (will be assessed using the questionnaire of international Health Behaviour in School-aged Children [HBSC] survey)

  3. Anthropometric measures [15 month]

    (will be assessed using the questionnaire of international Health Behaviour in School-aged Children [HBSC] survey)

  4. Age of puberty in girls [15 month]

    (will be assessed using the questionnaire of international Health Behaviour in School-aged Children [HBSC] survey)

Eligibility Criteria

Criteria

Ages Eligible for Study:
11 Years to 15 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Case :

  • Children conceived by Intraconjugal In Vitro Fertilization/Intracytoplasmic Sperm Injection treatment

  • Children aged 11-15 years

  • Singleton and twins

  • School children

  • Control :

  • Children born spontaneously (without IVF)

  • Children aged 11-15 years

  • Children in the same place of schooling of the case

Exclusion Criteria:
  • Case :

  • Children not born by Intraconjugal In Vitro Fertilization/Intracytoplasmic Sperm Injection treatment (donor)

  • Children whose parents refuse the participation

  • Triplet and more pregnancies

  • Children who cannot attend ordinary school

  • Children from families where an infant has passed away

  • When the participation agreement was not signed

  • Control :

  • Children whose parents have benefited ART

  • When the participation agreement was not signed

  • Children whose aged and sex are unknown

  • Triplet and more pregnancies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Saint Joseph de Marseille Marseille France 13008

Sponsors and Collaborators

  • Hospital St. Joseph, Marseille, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Pierre Boyer, Head of Assisted Reproductive Technologies Laboratory, Hospital St. Joseph, Marseille, France
ClinicalTrials.gov Identifier:
NCT02636179
Other Study ID Numbers:
  • RCB 2015-A00997-42
First Posted:
Dec 21, 2015
Last Update Posted:
Dec 21, 2015
Last Verified:
Dec 1, 2015
Keywords provided by Pierre Boyer, Head of Assisted Reproductive Technologies Laboratory, Hospital St. Joseph, Marseille, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 21, 2015